12. December 2023
honert advises Aristo Pharma GmbH on seed investment in FemTech start-up VaRi Bioscience GmbH
PRESS RELEASE
Munich, 12 December 2023
honert provided comprehensive legal and tax advice to Aristo Pharma GmbH on a seed investment in VaRi Bioscience GmbH.
Aristo Pharma GmbH, headquartered in Berlin, employs around 1,700 people at five different production sites in Germany and Spain and focuses on the manufacture and distribution of generics.
VaRi Bioscience GmbH is an innovative German biotech company from Berlin-Brandenburg that is doing pioneering work in the field of female health.
The Advisors:
honert (Munich): Dr. Kai-Klemens Wehlage (lead, venture capital, corporate law), Sven Fritsche (venture capital, tax), Peter Kipp und Veronika Nößner (both venture capital).
We are here for you
For more information please contact
Sven Fritsche
honert munich
Partner, Attorney-at-Law, Tax Advisor
Venture Capital, Tax, Corporate, Management Participation, M&A, Gesellschaftsrecht
| phone | +49 (89) 388 381 0 |
| [email protected] |
Veronika Nößner
honert munich
Attorney-at-Law
Business Law, Corporate, M&A, Gesellschaftsrecht, Allgemeines Wirtschaftsrecht
| phone | +49 (89) 388 381 0 |
| [email protected] |
Dr. Kai-Klemens Wehlage
honert munich
Partner, Attorney-at-Law
M&A, Venture Capital, Corporate
| phone | +49 (89) 388 381 0 |
| [email protected] |